Literature DB >> 1281995

Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart.

T Sugimoto1, H Tsuchimochi, C G McGregor, H Mutoh, T Shimizu, Y Kurachi.   

Abstract

PAF decreases cardiac contractility and blood pressure. To characterize the cardiac PAF receptor, we screened a human ventricular cDNA library in a low stringency condition, using a PCR product derived from guinea pig lung PAF receptor as a probe. Four clones were obtained and named HV1-4. In Xenopus oocytes injected with cRNA derived from HV3 or 4 but not from HV1 or 2, PAF elicited a Ca(2+)-activated Cl- current. HV3 and HV4 were duplicate clones, encoding a 342 amino-acid polypeptide which was identical to that of the human leukocyte PAF receptor. However, a portion of the 5' untranslated region of HV3 (or 4) was different from that of the leukocyte receptor cDNA. Northern blotting of human ventricles and atria using the HV3 insert showed a single band of approximately 4 kb. These results suggest a tissue-specific translational mechanism responsible for regulation of the expression of the PAF receptor mRNA in these tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281995     DOI: 10.1016/0006-291x(92)92245-s

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages.

Authors:  S Ishii; Y Matsuda; M Nakamura; I Waga; K Kume; T Izumi; T Shimizu
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.

Authors:  T Nagase; S Ishii; K Kume; N Uozumi; T Izumi; Y Ouchi; T Shimizu
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 3.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 4.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

5.  Long-lasting inhibitory activity of the hetrazepinic BN 50730 on exudation and cellular alterations evoked by PAF and LPS.

Authors:  A L Pires; P M e Silva; C Pasquale; H C Castro-Faria-Neto; P T Bozza; R S Cordeiro; G A Rae; P Braquet; V Lagente; M A Martins
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Tissue-specific response of the human platelet-activating factor receptor gene to retinoic acid and thyroid hormone by alternative promoter usage.

Authors:  H Mutoh; T Fukuda; T Kitamaoto; S Masushige; H Sasaki; T Shimizu; S Kato
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation.

Authors:  T Izumi; S Kishimoto; T Takano; M Nakamura; Y Miyabe; M Nakata; C Sakanaka; T Shimizu
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

8.  Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism.

Authors:  Kathryn E Baker; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

9.  Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.

Authors:  S Ishii; T Kuwaki; T Nagase; K Maki; F Tashiro; S Sunaga; W H Cao; K Kume; Y Fukuchi; K Ikuta; J Miyazaki; M Kumada; T Shimizu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 10.  Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy.

Authors:  Ildefonso Alves da Silva Junior; Luciana Nogueira de Sousa Andrade; Sonia Jancar; Roger Chammas
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.